This meeting is a little strange so close to the PDUFA date. In searching thru the FDA's site, I couldn't find another example of such a meeting(which date back to 2007).
I suspect the FDA issued something to AMRN earlier and they requested a meeting to clarify. It certainly has a hint of bearishness to it.